And those sera antibody‐positive patients with ACRBP high expression tumor include one in Stage II and six in Stages III and IV, whereas sera antibody‐positive patients with ACRBP low expression tumor include four in Stage I–II and five in Stages III–IV (Figure 4B). This evidence concerns the gene ACRBP and neoplasm.